Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 53, 2023 - Issue 5
Submit an article Journal homepage
79
Views
0
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Pharmacokinetics of the novel 5-HT4 receptor agonist, DA-6886, in dogs

Dae Young Leea Research Center, Dong-A ST Co. Ltd, Yongin, South KoreaView further author information
&
Hee Eun Kangb College of Pharmacy and Integrated Research Institute of Pharmaceutical Sciences, The Catholic University of Korea, Bucheon, South KoreaCorrespondence[email protected]
View further author information
Pages 438-444 | Received 11 Aug 2023, Accepted 19 Sep 2023, Published online: 02 Oct 2023

References

  • Chiou WL. 1978. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. J Pharmacokinet Biopharm. 6(6):539–546. doi: 10.1007/BF01062108.
  • Davies B, Morris T. 1993. Physiological parameters in laboratory animals and humans. Pharm Res. 10(7):1093–1095. doi: 10.1023/a:1018943613122.
  • Fukuchi Y, Toshimoto K, Mori T, Kakimoto K, Tobe Y, Sawada T, Asaumi R, Iwata T, Hashimoto Y, Nunoya K-I, et al. 2017. Analysis of nonlinear pharmacokinetics of a highly albumin-bound compound: contribution of albumin-mediated hepatic uptake mechanism. J Pharm Sci. 106(9):2704–2714. doi: 10.1016/j.xphs.2017.04.052.
  • Galligan JJ. 2021. Colonic 5-HT4 receptors are targets for novel prokinetic drugs. Neurogastroenterol Motil. 33(4):e14125. doi: 10.1111/nmo.14125.
  • Gibaldi M, Perrier D, editors. 1982. Pharmacokinetics. 2nd ed. New York: Marcel-Dekker Inc.
  • Hummel J, McKendrick S, Brindley C, French R. 2009. Exploratory assessment of dose proportionality: review of current approaches and proposal for a practical criterion. Pharm Stat. 8(1):38–49. doi: 10.1002/pst.326.
  • Kang HE, Jung HY, Cho YK, Kim SH, Sohn SI, Baek SR, Lee MG. 2009. Pharmacokinetics of liquiritigenin in mice, rats, rabbits, and dogs, and animal scale-up. J Pharm Sci. 98(11):4327–4342. doi: 10.1002/jps.21702.
  • Kwon MH, Lee DY, Kang HE. 2021. Development and validation of an LC–MS/MS method for quantification of the novel antibacterial candidate DA-7010 in plasma and application to a preclinical pharmacokinetic study. Pharmaceuticals. 14(2):163. doi: 10.3390/ph14020163.
  • Lee DY, Kang HE. 2022. Pharmacokinetics of DA-6886, a new 5-HT4 receptor agonist, in rats. Pharmaceutics. 14(4):702. doi: 10.3390/pharmaceutics14040702.
  • Lee MJ, Cho KH, Park HM, Sung HJ, Choi S, Im W. 2014. Pharmacological profile of DA-6886, a novel 5-HT4 receptor agonist to accelerate colonic motor activity in mice. Eur J Pharmacol. 735:115–122. doi: 10.1016/j.ejphar.2014.03.061.
  • Li Z, Gao Y, Yang C, Xiang Y, Zhang W, Zhang T, Su R, Lu C, Zhuang X. 2020. Assessment and confirmation of species difference in nonlinear pharmacokinetics of atipamezole with physiologically based pharmacokinetic modeling. Drug Metab Dispos. 48(1):41–51. doi: 10.1124/dmd.119.089151.
  • Manabe N, Wong BS, Camilleri M. 2010. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs. 19(6):765–775. doi: 10.1517/13543784.2010.482927.
  • Moon JH, Lee MJ, Cho KH, Im W, Choi SH. 2014. Effects of DA-6886 on colonic motility in conscious guinea pigs. Gastroenterology. 146(5):S357–S358. doi: 10.1016/S0016-5085(14)61293-2.
  • Parrott N, Lukacova V, Fraczkiewicz G, Bolger MB. 2009. Predicting pharmacokinetics of drugs using physiologically based modeling – application to food effects. AAPS J. 11(1):45–53. doi: 10.1208/s12248-008-9079-7.
  • Smith BP, Vandenhende FR, DeSante KA, Farid NA, Welch PA, Callaghan JT, Forgue ST. 2000. Confidence interval criteria for assessment of dose proportionality. Pharm Res. 17(10):1278–1283. doi: 10.1023/a:1026451721686.
  • Uno Y, Shimizu M, Ogawa Y, Makiguchi M, Kawaguchi H, Yamato O, Ishizuka M, Yamazaki H. 2022. Molecular and functional characterization of flavin-containing monooxygenases in pigs, dogs, and cats. Biochem Pharmacol. 202:115125. doi: 10.1016/j.bcp.2022.115125.
  • US FDA/Center for Drug Evaluation and Research. 2018. Bioanalytical method validation guidance for industry; [accessed 2023 Jul 26]. https://www.fda.gov/media/70858/download.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.